387 related articles for article (PubMed ID: 18515851)
1. Comprehensive approach of donepezil and psychosocial interventions on cognitive function and quality of life for Alzheimer's disease: the Osaki-Tajiri Project.
Meguro M; Kasai M; Akanuma K; Ishii H; Yamaguchi S; Meguro K
Age Ageing; 2008 Jul; 37(4):469-73. PubMed ID: 18515851
[No Abstract] [Full Text] [Related]
2. A comparison of donepezil and galantamine in the treatment of cognitive symptoms of Alzheimer's disease: a meta-analysis.
Harry RD; Zakzanis KK
Hum Psychopharmacol; 2005 Apr; 20(3):183-7. PubMed ID: 15700322
[TBL] [Abstract][Full Text] [Related]
3. Clinical inquiries. Does treatment with donepezil improve memory for patients with mild cognitive impairment?
Stiles MM; Martin S; Persons RK
J Fam Pract; 2006 May; 55(5):435-6. PubMed ID: 16670040
[No Abstract] [Full Text] [Related]
4. Donepezil treatment of severe Alzheimer's disease in nursing home settings. A responder analysis.
Jelic V; Haglund A; Kowalski J; Langworth S; Winblad B
Dement Geriatr Cogn Disord; 2008; 26(5):458-66. PubMed ID: 18984956
[TBL] [Abstract][Full Text] [Related]
5. Donepezil-induced nightmares in mild cognitive impairment.
Kitabayashi Y; Ueda H; Tsuchida H; Yamashita T; Narumoto J; Fukui K
Psychiatry Clin Neurosci; 2006 Feb; 60(1):123-4. PubMed ID: 16472374
[No Abstract] [Full Text] [Related]
6. No donepezil discontinuation effect in patients with Alzheimer's disease who were switched to rivastigmine after failing to benefit from donepezil treatment.
Auriacombe S; Pere JJ;
Curr Med Res Opin; 2003; 19(8):715-7. PubMed ID: 14687442
[No Abstract] [Full Text] [Related]
7. Investigation of responders and non-responders to long-term donepezil treatment.
Inoue J; Hoshino R; Nojima H; Ishida W; Okamoto N
Psychogeriatrics; 2010 Jun; 10(2):53-61. PubMed ID: 20738808
[TBL] [Abstract][Full Text] [Related]
8. Effect of donepezil on the continuum of depressive symptoms, mild cognitive impairment, and progression to dementia.
Panza F; Frisardi V; Capurso C; D'Introno A; Colacicco AM; Chiloiro R; Dellegrazie F; Di Palo A; Capurso A; Solfrizzi V
J Am Geriatr Soc; 2010 Feb; 58(2):389-90. PubMed ID: 20370868
[No Abstract] [Full Text] [Related]
9. New drug treatment for Alzheimer's disease. SMAC's advice on use of donepezil is contradictory.
Baxter T; Black D; Prempeh H
BMJ; 1998 Oct; 317(7163):946. PubMed ID: 9841011
[No Abstract] [Full Text] [Related]
10. Verbal repetition in patients with Alzheimer's disease who receive donepezil.
Asp E; Cloutier F; Fay S; Cook C; Robertson ML; Fisk J; Dei DW; Rockwood K
Int J Geriatr Psychiatry; 2006 May; 21(5):426-31. PubMed ID: 16676290
[TBL] [Abstract][Full Text] [Related]
11. Improving functioning in patients with Alzheimer's.
J Psychosoc Nurs Ment Health Serv; 1998 May; 36(5):11-2. PubMed ID: 9604834
[No Abstract] [Full Text] [Related]
12. Donepezil for Alzheimer's disease.
Benjamin B; Burns A
Expert Rev Neurother; 2007 Oct; 7(10):1243-9. PubMed ID: 17939763
[TBL] [Abstract][Full Text] [Related]
13. Effect of donepezil on motor and cognitive function in Huntington disease.
Cubo E; Shannon KM; Tracy D; Jaglin JA; Bernard BA; Wuu J; Leurgans SE
Neurology; 2006 Oct; 67(7):1268-71. PubMed ID: 17030764
[TBL] [Abstract][Full Text] [Related]
14. [Efficacy, efficiency and evidence -- studies on donepezil].
Wallesch CW; Ebert AD
Fortschr Neurol Psychiatr; 2004 Oct; 72(10):555-6. PubMed ID: 15472778
[No Abstract] [Full Text] [Related]
15. Donepezil in the treatment of patients with Alzheimer's disease.
Tsuno N
Expert Rev Neurother; 2009 May; 9(5):591-8. PubMed ID: 19402770
[TBL] [Abstract][Full Text] [Related]
16. Donepezil update.
Drug Ther Bull; 1998 Aug; 36(8):60-1. PubMed ID: 9876403
[No Abstract] [Full Text] [Related]
17. Donepezil in Alzheimer's disease: what to expect after 3 years of treatment in a routine clinical setting.
Wallin AK; Andreasen N; Eriksson S; Båtsman S; Nasman B; Ekdahl A; Kilander L; Grut M; Rydén M; Wallin A; Jonsson M; Olofsson H; Londos E; Wattmo C; Eriksdotter Jonhagen M; Minthon L;
Dement Geriatr Cogn Disord; 2007; 23(3):150-60. PubMed ID: 17312368
[TBL] [Abstract][Full Text] [Related]
18. Drug may slow brain shrinkage in pre-Alzheimer's disease.
Mayo Clin Health Lett; 2006 Dec; 24(12):4. PubMed ID: 17304693
[No Abstract] [Full Text] [Related]
19. Drug may temporarily slow progression of mild cognitive impairment.
Mayo Clin Womens Healthsource; 2005 Aug; 9(8):3. PubMed ID: 16015194
[No Abstract] [Full Text] [Related]
20. Ginkgo biloba extract EGb 761(R), donepezil or both combined in the treatment of Alzheimer's disease with neuropsychiatric features: a randomised, double-blind, exploratory trial.
Yancheva S; Ihl R; Nikolova G; Panayotov P; Schlaefke S; Hoerr R;
Aging Ment Health; 2009 Mar; 13(2):183-90. PubMed ID: 19347685
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
